ASBPW
Aspire Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.02
+31.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.33x
- Price / sales
- 39.96x
- Price / cash flow
- -0.54x
Enterprise value
- Enterprise value
- -$8.3M
- EV / sales
- -84.63x
- EV / EBITDA
- -2.51x
- EV / EBIT
- 1.17x
- Market cap
- $3.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026